Discovery of a Novel Classof Highly Potent, Selective,ATP-Competitive, and Orally Bioavailable Inhibitors of the MammalianTarget of Rapamycin (mTOR).

Autor: Takeuchi, Craig S., Kim, Byung Gyu, Blazey, Charles M., Ma, Sunghoon, Johnson, Henry W. B., Anand, Neel K., Arcalas, Arlyn, Baik, Tae Gon, Buhr, Chris A., Cannoy, Jonah, Epshteyn, Sergey, Joshi, Anagha, Lara, Katherine, Lee, Matthew S., Wang, Longcheng, Leahy, James W., Nuss, John M., Aay, Naing, Aoyama, Ron, Foster, Paul
Zdroj: Journal of Medicinal Chemistry; Vol. 56 Issue 6, p2218-2234, 17p
Databáze: Supplemental Index